Beyond Panel-Based Testing: Exome Analysis Increases Sensitivity for Diagnosis of Genetic Kidney Disease.

Parker C WilsonLatisha Love-GregoryMeagan CorlissSamantha McNultyJonathan W HeuselJoseph P Gaut

Published in: Kidney360 (2020)

These results highlight the importance of a broad and collaborative approach between the clinical laboratory and their physician clients that employs additional analysis when a targeted panel of kidney disease-causing genes does not return a clinically meaningful result.

Keyphrases

genome wide
emergency department
primary care
transcription factor
drug delivery
human immunodeficiency virus
antiretroviral therapy